Pine Pharmaceuticals, LLC recalls Bevacizumab 1.25 MG/0.05 ML Solution for Injection, 1 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 River
Recalled October 25, 2023 · FDA recall D-0050-2024 · Pine Pharmaceuticals
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
2862 Syringes
Sold at
Nationwide within the United States
Description
Lack of Assurance of Sterility
Product
Bevacizumab 1.25 MG/0.05 ML Solution for Injection, 1 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Manufacturer(s)
Pine Pharmaceuticals, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →